倍他乐克联合通心络治疗老年心绞痛的临床效果
鱼建平
陕西省子长县人民医院内科,陕西 延安,717300
浏览次数:119次 下载次数:327次
摘要:
目的 对老年心绞痛患者经通心络联合倍他乐克治疗的临床效果进行探究。方法 将我院 90例老年心绞痛患者依照住院号分为对照组与观察组,各 45例。对照组采用常规治疗,观察组在对照组基础上采用通心络联合倍他乐克治疗,比较两组治疗效果。结果 观察组治疗总有效率高于对照组,SDS、SAS评分低于对照组(P<0.05)。治疗 1个月后,两组患者的 ST-T 改变率、平均发作频次、平均总持续时间、平均最长持续时间均改善,且观察组优于对照组(P<0.05);两组不良反应总发生率比较,差异无统计学意义(P>0.05)。结论 在常规治疗基础上加以通心络、倍他乐克联合治疗老年心绞痛患者效果显著,安全有效。
关键词: 老年心绞痛;通心络;倍他乐克;动态心电图
中图分类号:R541.4文献标志码:A文章编号:2096-1413(2018)07-0038-02
Clinical efficacy of betaloc combined with Tongxinluo in the treatment of senile
angina pectoris
YU Jian-ping
(Internal Medicine Department, Zichang County People`s Hospital, Yan`an 717300, China)
ABSTRACT: Objective To explore the clinical effect of Tongxinluo combined with betaloc in elderly patients with anginapectoris. Methods Ninety cases of elderly patients with angina pectorisin our hospital were divided into control group and observation group according to the admission number,with 45 cases in each group.The control group was treated with routine treatment,the observation group was treated with Tongxinluo combined with betaloc on the basis of the control group. The curative effects were compared between the two groups. Results The total effective rate in the observation group was significantly higher than that in the control group,the scores of SDS,SAS were lower than those in the control group (P<0.05).At 1 month of treatment,the change rates,the average frequency of occurrence,the average total duration,the aver-age longestduration ofST-T segmentin the two group simproved,and those ofthe observation group were better than thecontrol group (P<0.05).There was no significant difference in the total incidences of adverse reactions between the two groups (P>0.05). Conclusion Tongxinluo combined with betaloc on the basis of the routine treatment in elderly patients with angina pectoris has obvious effect, which is safe and effective. KEYWORDS: senile angina pectoris ; Tongxinluo; betaloc; dynamic electrocardiogram
参考文献:
[1] 樊永恒 . 联用倍他乐克和通心络治疗冠心病心绞痛的效果探析 [J].当代医药论丛 ,2016,14(23):14-15.
[2] 郭杰 . 倍他乐克与通心络联合治疗冠心病心绞痛的临床分析 [J]. 中国实用医药 ,2016,11(33):120-121.
[3] 胡京津 , 张代刚 . 倍他乐克、通心络联合治疗冠心病心绞痛的临床疗效观察 [J]. 中国实用医药 ,2015,10(34):14-16.
[4] 黄丽 . 倍他乐克与通心络对冠心病心绞痛的治疗效果研究 [J]. 海峡药学 ,2016,28(3):170-171.
[5] 戴路刚 . 倍他乐克联合通心络治疗冠心病心绞痛的临床应用疗效评价 [J]. 中国医药指南 ,2016,14(33):128-129.